Protective efficacy of an IL‐12‐expressing baculoviral malaria vaccine
- 26 October 2017
- journal article
- research article
- Published by Wiley in Parasite Immunology
- Vol. 39 (12)
Abstract
Summary: Interleukin‐12 (IL‐12) plays an important role in antigen‐specific adaptive immunity against Plasmodium sporozoites, and this requirement allows for a new approach to developing an effective malaria vaccine. In this study, we examined whether IL‐12 could enhance protective efficacy of a baculovirus‐based malaria vaccine. For this aim, a baculoviral vector expressing murine IL‐12 (mIL‐12) under the control of CMV promoter (BES‐mIL‐12‐Spider) and a baculoviral vector expressing Plasmodium falciparum circumsporozoite protein (PfCSP) with post‐transcriptional regulatory element of woodchuck hepatitis virus (BDES‐sPfCSP2‐WPRE‐Spider) were generated. BES‐mIL‐12‐Spider produced bioactive IL‐12 which activates splenocytes, resulting in induction of IFN‐γ. When co‐immunized with BES‐mIL‐12‐Spider and BDES‐sPfCSP2‐WPRE‐Spider, the mouse number for high IgG2a/IgG1 ratios and the geometric mean in this group were both increased as compared with those of the other groups, indicating a shift towards a Th1‐type response following immunization with BES‐mIL‐12‐Spider. Finally, immunization with BDES‐sPfCSP2‐WPRE‐Spider plus BES‐mIL‐12‐Spider had a higher protective efficacy (73%) than immunization with BDES‐sPfCSP2‐WPRE‐Spider alone (30%) against challenge with transgenic Plasmodium berghei sporozoites expressing PfCSP. These results suggest that co‐administration of IL‐12 expressing baculoviral vector, instead of IL‐12 cDNA, with viral‐vectored vaccines provides a new feasible vaccine platform to enhance Th1‐type cellular immune responses against Plasmodium parasites.Keywords
Funding Information
- Japan Society for the Promotion of Science (21390126, 24659460, 25305007, 26860278)
- Medical Research Council (MR/N00227X/1)
This publication has 28 references indexed in Scilit:
- Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite ProteinPLOS ONE, 2013
- Interferon-γ, a valuable surrogate marker of Plasmodium falciparum pre-erythrocytic stages protective immunityMalaria Journal, 2011
- Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1- and Apical Membrane Antigen 1-Based VaccinesPLOS ONE, 2010
- Baculovirus-Based Nasal Drop Vaccine Confers Complete Protection against Malaria by Natural Boosting of Vaccine-Induced Antibodies in MiceInfection and Immunity, 2010
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- A Baculovirus Dual Expression System-Based Malaria Vaccine Induces Strong Protection againstPlasmodium bergheiSporozoite Challenge in MiceInfection and Immunity, 2009
- Immunization with Radiation-Attenuated Plasmodium berghei Sporozoites Induces Liver cCD8α+DC that Activate CD8+T Cells against Liver-Stage MalariaPLOS ONE, 2009
- Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challengeVaccine, 2008
- Class II-Restricted Protective Immunity Induced by Malaria SporozoitesInfection and Immunity, 2008
- Direct Immunization of Malaria DNA Vaccine into the Liver by Gene Gun Protects against Lethal Challenge of Plasmodium berghei SporozoiteBiochemical and Biophysical Research Communications, 2000